entertainment -WSS

entertainment

author：entertainment 2025-10-02 17:22:42 - browse：54

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： He's 19 months old and has one of the world’s rarest diseases

hotspot

WSS

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

The public health thinking behind the CDC’s new Covid guidance

Biden's 'march

State of the Union pitch: Bigger Medicare drug price negotiations

First over

Where are patients getting their prescriptions for GLP

Wikipedia

entertainment

explore

Medical records are filled with copy

Genentech weighs delaying cancer therapy after drug pricing law

At least 13 dead in Texas as scorching temps continue

Who are the detained American citizens released from prison in Iran?

After affirmative action ruling, medical educators look to 'holistic review'

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Alkermes shareholders re

For AI in health care standards, federal regulators join with industry group

Anesthesiologist group: stop taking Ozempic before surgery

He's 19 months old and has one of the world’s rarest diseases

hotspot

Lack of health data on LGBTQ+ people has serious consequences

Biden's 'march

The history of OxyContin, told through Purdue Pharma documents

Stem cell biologist probes earliest stages of human development

State of the Union pitch: Bigger Medicare drug price negotiations

Maui funeral service workers on devastation of fires: 'I'm in shock'

focus

hotspot

entertainment

knowledge